COVID-19: Bharat Biotech to begin pediatric trials of Covaxin from June 1

He spoke about several issues related to vaccination, including the dosing interval.

Corona vaccine: As the vaccination drive in India somehow continues amid the shortage of doses, there are still many questions surrounding the vaccination. For its part, while the government is taking several measures to address the hesitation about vaccines and other concerns, Bharat Biotech Head of Business Development and International Advocacy, Dr Raches Ella held a virtual interaction with the members of the FICCI Ladies Organization (FLO) on Saturday around the topic, ‘All About Vaccines’. During this interview, Dr. Ella said that a few side effects of vaccination were common and that it should not deter anyone from getting vaccinated.

During the session, Dr. Ella also said that the developer was given the green light to conduct pediatric trials of the vaccine in children between the ages of 2 and 18, and that these trials could begin June 1. Bharat Biotech has co-developed Covaxin with the nodal Health Agency, Indian Council of Medical Research, and the vaccine is currently used to vaccinate humans.

View live updates about the corona virus here

However, India is facing a massive vaccine shortage, leading to several states not starting or halting vaccination activity for people between the ages of 18 and 44. Meanwhile, he said Bharat Biotech hopes to increase its vaccine production capacity to 70 crore by the end of 2021.

Speaking more about the side effects that vaccines cause, Dr. Ella said that even if the purest form of water were injected into someone, there would be potential for some of the reactions, because that’s the way the body works. He added that a healthy body should respond when a foreign element enters the body, claiming that the same was the reason why people had side effects from vaccines.

He spoke about several issues related to vaccination, including the dosing interval. Dr. Ella said the gap should ideally be anywhere from two weeks to six weeks, but even if someone missed that schedule, don’t panic and just go as soon as possible to get the second dose. He also said that a good antibody response can be developed about three months after the second dose, adding that the vaccines were doing well enough at this point and whether booster shots are needed depends on future variants.

He also said cases of coronavirus can be seen after the first vaccination dose, as the first dose provided only partial efficacy as the immune system takes time to develop. He explained that after the second dose, the severity of the COVID infection is likely to be significantly lower.

He also debunked misinformation spread on WhatsApp, saying couples trying to conceive and menstruating women can take the vaccine.

Get current stock quotes from BSE, NSE, US market and latest NAV, mutual fund portfolio, view latest IPO news, top performing IPOs, calculate your tax with income tax calculator, know the best profits in the market, the biggest losers and the best equity funds. Like us on Facebook and Follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay up to date with the latest Biz news and updates.

Comments are closed.